24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term and long-term potential.
In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.
Ebola fears have subsided and the development of a vaccine or related drugs has been put on the back burner for most, but one biotech made waves in the market Monday morning.
Chris Lange thinkstockJuly 29, 2015: Markets opened higher on Wednesday and two of the three major indexes spend all day trading above the break-even line; only the Nasdaq Composite took a brief visit into…
ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis C vaccines (HCV) Harvoni and Solvaldi. For the most part the resulting…
ThinkstockMerck & Co. Inc. (NYSE: MRK) reported its second-quarter financial results Tuesday before the markets opened. The pharmaceutical giant had $0.86 in earnings per share (EPS) on $9.8 billion in revenue compared…
Chris Lange ThinkstockMerck & Co. Inc. (NYSE: MRK) reports on Tuesday morning comes into earnings with shares up only 2.7% or so year to date, and up only about 1.7% from a year ago.…
Chris Lange ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials.…
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK)…
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay a solid dividend and have a good potential for growth, they all…
thinkstockJune 26, 2015: Markets opened higher on Friday but tech stocks almost immediately dragged down the Nasdaq Composite and eventually weighed on the S&P 500 index as well. A weak report from…
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
thinkstockJune 22, 2015: Markets opened higher on Monday as investors appeared optimistic that Greece and the European Central Bank would strike a deal. That hasn’t happened yet today. Gold dropped 1.5% and…
thinkstockJune 12, 2015: Markets opened lower on Friday as a solution to the Greek-European Union seems to draw further away from negotiators. Energy and healthcare stocks both opened weak and were able…
